Zacks Investment Research
08 Jul 2026, 14:01 UTC · 8w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Pfizer's consensus earnings estimate for the current quarter is $0.68 per share, a year-over-year decrease of 12.8%. — Significant double-digit declines in quarterly earnings typically signal weakening fundamentals and downward pressure on stock price.
-0.40Pfizer's consensus earnings estimate for the current fiscal year is $2.98, representing a 7.5% decrease from the prior year. — Annual earnings contraction indicates a broader negative trend in profitability for the company.
-0.30Pfizer's earnings estimate for the next fiscal year is $2.86, a projected 4.2% decrease from the previous year. — Continued expected declines in future earnings suggest the company has not yet reached a recovery inflection point.
-0.20Continue reading
6 related stories
Top 3 movers · tap to explore
Pfizer's shares have returned -6.3% over the past month, underperforming both the Zacks S&P 500 composite (1.6%) and the Large Cap Pharmaceuticals industry (9.1%). — Significant relative underperformance suggests negative investor sentiment and a loss of momentum compared to peers.
-0.10Which stocks this story touches
The stock has underperformed the S&P 500 and its industry, with negative year-over-year earnings projections.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
1d ago
